Salud financiera de hoja de balance de Collegium Pharmaceutical
Salud financiera controles de criterios 3/6
Collegium Pharmaceutical tiene un patrimonio de accionistas total de $195.4M y una deuda total de $667.2M, lo que sitúa su ratio deuda-patrimonio en 341.4%. Sus activos y pasivos totales son $1.1B y $947.9M respectivamente. El BAIT de Collegium Pharmaceutical es de $190.6M, por lo que su ratio de cobertura de intereses es de 2.8. Tiene efectivo e inversiones a corto plazo que ascienden a $310.5M.
Información clave
341.4%
Ratio deuda-patrimonio
US$667.17m
Deuda
| Ratio de cobertura de intereses | 2.8x |
| Efectivo | US$310.55m |
| Patrimonio | US$195.43m |
| Total pasivo | US$947.88m |
| Activos totales | US$1.14b |
Actualizaciones recientes sobre salud financiera
These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Reasonably Well
Feb 24
Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly
Nov 12Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?
Aug 09Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?
Mar 10Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?
Oct 18Collegium Pharmaceutical (NASDAQ:COLL) Has A Somewhat Strained Balance Sheet
Jun 24Recent updates
Collegium Pharmaceutical Q4: The Beat Goes On
Feb 26These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Reasonably Well
Feb 24There's No Escaping Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Muted Revenues
Jan 05Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly
Nov 12Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?
Aug 09Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?
Mar 10Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?
Oct 18Collegium Pharmaceutical (NASDAQ:COLL) Has A Somewhat Strained Balance Sheet
Jun 24Collegium Pharmaceutical: Oversold And Cheap
Jun 12Collegium Pharmaceutical: Thoughts After Another Strategic Move
Feb 20There Is A Reason Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Price Is Undemanding
Feb 15We Think Collegium Pharmaceutical (NASDAQ:COLL) Can Stay On Top Of Its Debt
Oct 30Sizing Up Collegium Pharmaceuticals
Oct 04Collegium Pharmaceutical: Moving Closer To The Top
Jul 12Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Compensation Is Looking A Bit Stretched At The Moment
May 14Shareholders Will Be Pleased With The Quality of Collegium Pharmaceutical's (NASDAQ:COLL) Earnings
May 13We Think Collegium Pharmaceutical (NASDAQ:COLL) Is Taking Some Risk With Its Debt
May 01Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($537.6M) de COLL superan a sus pasivos a corto plazo ($457.9M).
Pasivo a largo plazo: Los activos a corto plazo de COLL ($537.6M) superan a sus pasivos a largo plazo ($490.0M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de COLL (182.5%) se considera alta.
Reducción de la deuda: COLL's debt to equity ratio has increased from 12.6% to 341.4% over the past 5 years.
Cobertura de la deuda: La deuda de COLL está bien cubierta por el flujo de caja operativo (41.2%).
Cobertura de intereses: Los pagos de intereses de la deuda de COLL no están bien cubiertos por el BAIT (2.8x cobertura).